| (84) |
Benannte Vertragsstaaten: |
|
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
| (30) |
Priorität: |
02.01.2001 DE 10100053
|
| (43) |
Veröffentlichungstag der Anmeldung: |
|
22.10.2003 Patentblatt 2003/43 |
| (73) |
Patentinhaber: |
|
- IMTM GmbH
39120 Magdeburg (DE)
- Ansorge, Siegfried
39291 Hohenwarte (DE)
|
|
| (72) |
Erfinder: |
|
- ANSORGE, Siegfried
39291 Hohenwarte (DE)
- LENDECKEL, Uwe;
Inst. Exp. Innere Medizin
39120 Magdeburg (DE)
- STRIGGOW, Frank,
KeyNeurotek AG i.G.
39120 Magdeburg (DE)
- NEUBERT, Klaus,
Martin-Luther-Uni. Biochemie/Biotech.
06120 Halle (DE)
- REYMANN, Klaus;
c/o F.A.N. GMBH
39120 Magdeburg (DE)
- KÄHNE, Thilo
Leipziger Strasse 44,
39120 Magdeburg (DE)
|
| (74) |
Vertreter: Koepe, Gerd L. et al |
|
Koepe & Partner
Robert-Koch-Strasse 1
80538 München
80538 München (DE) |
| (56) |
Entgegenhaltungen: :
EP-B- 0 896 538
WO-A-98/05333
WO-A2-2007/127204
US-A- 2003 148 961
|
EP-B- 1 289 559
WO-A1-01/19866
US-A- 5 763 576
|
|
| |
|
|
- MARK-KS ET AL.: "Stroke: development, prevention and treatment with peptidase inhibitors"
PEPTIDES, Bd. 21, 2000, Seiten 1965-1973, XP002202700
- LOGAN-ME ET AL.: "Bestatin protection against hypoxia induced injury in the guinea-pig
heart" JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, Bd. 15, Nr. Suppl.4, 11. Juli
1983 (1983-07-11), Seite 32 XP008004193
- AUGUSTYNS K ET AL: "THE UNIQUE PROPERTIES OF DIPEPTIDYL-PEPTIDASE IV (DPP IV/CD26)
AND THE THERAPEUTIC POTENTIAL OF DPP IV INHIBITORS" CURRENT MEDICINAL CHEMISTRY, BENTHAM
SCIENCE PUBLISHERS BV, BE, Bd. 6, Nr. 4, 1999, Seiten 311-327, XP000870290 ISSN: 0929-8673
- HALLE J.L.: 'Enzymkinetik: eine Einführung für biochemiker, Mediziner, Biologen, Chemiker
und Pharmazeuten', 1987, VEB GUSTAV FISCHER VERLAG
- BARTH A. ET AL: 'Untersuchungen zur Reinigung und Charakterisierung der Dipeptidylaminopeptidase
IV' ACTA BIOL MED GER Bd. 32, Nr. 2-3, 1974, Seite 157-174
- SEDO A. ET AL: 'Dipeptidyl peptidase IV-like molecules: homologous proteins or homologous
activities?' BIOCHIM BIOPHYS ACTA Bd. 1550, Nr. 2, 17 Dezember 2001, Seite 107-16
- CHEN T. ET AL: 'Dipeptidyl peptidase IV gene family' ADV EXP MED BIOL. Bd. 524, 2003,
Seite 79-86
- KAKUTA H. ET AL: 'Fluorescent bioprobes for visualization of puromycin-sensitive aminopeptidase
in living cells' BIOORG MED CHEM LETT. Bd. 13, Nr. 1, 06 Januar 2003, Seite 83-86
- EVANS D.M.: 'Dipeptidyl peptidase IV inhibitors.' IDRUGS Bd. 5, Nr. 6, Juni 2002,
Seite 577-585
- STÖCKEL-MASCHEK A. ET AL: 'Potent inhibitors of dipeptidyl peptidase IV and their
mechanisms of inhibition' ADV EXP BIOL MED Bd. 477, 2000, Seite 117-123
- WENFANG XU ET AL: 'Progress in the development of aminopeptidase N (APN/CD13) inhibitors'
CURR MED CHEM - ANTI CANCER AGENTS Bd. 5, 2005, Seite 281-301
- BAUVOIS B. ET AL: 'Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological
evaluations, and therapeutic prospects' MEDICINAL RESEARCH REVIEWS Bd. 26, Nr. 1,
07 Oktober 2005, Seite 88-130
- ALBISTON A.L.: 'Membrane bound members of the M1 family: more than aminopeptidases'
PROTEIN AND PEPTIDES LETTERS Bd. 11, Nr. 5, 2004, Seite 491-500
- Biomol- Product Data Sheet Product: Actinonin
- ABBOTT C.A. ET AL: 'Post-proline-cleaving peptidases having DP IV like enzyme activity.
Post-proline peptidases' ADV EXP MED BIOL Bd. 477, 2000, Seite 103-109
- DURINX C. ET AL: 'Molecular characterization of dipeptidyl peptidase activity in serum:
soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides.'
EUR J BIOCHEM Bd. 267, Nr. 17, September 2000, Seite 5608-13
- DUKE-COHAN J.S.: 'Attractin: a cub-family protease involved in T cell-monocyte/macrophage
interactions.' ADV EXP MED BIOL Bd. 477, 2000, Seite 173-85
- RAWLINGS N.D.; BARRETT A.J.: 'Evolutionary families of metallopeptidases.' METHODS
ENZYMOL Bd. 248, 1995, Seite 183-228
- HEO J.H. ET AL: 'Matrix metalloproteinases increase very early during experimental
focal cerebral ischemia' J CEREB BLOOD FLOW METAB Bd. 19, Nr. 6, Juni 1999, Seite
624-33
- ROMANIC A.M. ET AL: 'Matrix metalloproteinase expression increases after cerebral
focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size'
STROKE Bd. 29, Nr. 5, Mai 1998, Seite 1020-30
- http://www.sigmaaldrich.com/catalog/search /ProductDetail/SIGMA/B8385 B8385 Bestatin
hydrochloride Data-sheet
- http://www.sigmaaldrich.com/catalog/search /ProductDetail/SIGMA/A1276 A1276 Amastatin
hydrochloride hydrate - Data-sheet
- http://www.brenda-enzymes.info/ Inhibition profiles for inhibitors: Actinonin, Bestatin,
Amastatin
|
|
